冠心病的治疗包括经皮冠脉介入治疗(PCI)、冠脉搭桥术(CABG)等。2型糖尿病患者具有较高的动脉粥样硬化发生率及较快的病情进展,从而增加患者再次血运重建的风险。FREEDOM试验研究证实了采用第一代药物洗脱支架行PCI治疗的糖尿病患者比行CABG的糖尿病患者面临更高的心血管不良事件及死亡风险。而随着支架的发展,新一代 Treatment of coronary heart disease including percutaneous coronary intervention (PCI), coronary artery bypass surgery (CABG) and so on. Patients with type 2 diabetes have a higher incidence of atherosclerosis and faster progression of the disease, thereby increasing the risk of revascularization in patients. FREEDOM trial study confirmed that patients with diabetes treated with PCI first-generation stent were at higher risk of cardiovascular events and death than those with CABG. With the development of the stent, a new generation